Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

NCT06831734 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilia A, Haemophilia B

Interventions

DRUG: Concizumab

Sponsor

Novo Nordisk A/S